KATE SMITH: Open Payments
NPI 1861431462 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,708 in 26 payments from 14 companies in 2025. Trend: 2023 $921 · 2024 $912 · 2025 $1,708
Food & beverage: $1,708
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $362 |
| Lilly USA, LLC | 4 | $274 |
| Novo Nordisk Inc | 2 | $239 |
| Eisai Inc. | 3 | $176 |
| Otsuka America Pharmaceutical, Inc. | 3 | $162 |
| Stryker Corporation | 1 | $161 |
| Vanda Pharmaceuticals Inc. | 1 | $93 |
| Amgen Inc. | 1 | $89 |
| Lundbeck LLC | 3 | $62 |
| PFIZER INC. | 1 | $22 |
Products named: BREZTRI, Wegovy, REXULTI, Leqembi, KISUNLA, FLOWTRIEVER, ZEPBOUND, FANAPT.
Industry payments across FL — which companies pay providers there.
